Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ (3,905,822)	$ (5,751,610)	$ (10,820,574)	$ (2,820,763)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense			300,898	2,893,658
Stock-based consulting expense			0	603,924
Stock-based 401K company common match			19,967	29,705
Depreciation expense			11,706	93,814
Operating lease expense			106,949	0
Loss on disposal of fixed assets related to lease termination			0	310,951
Bargain purchase gain from merger	0	0	0	(11,939,331)
Changes in assets and liabilities:
Prepaid expenses and other assets			1,935,067	1,908,520
Accounts payable			361,871	(1,521,516)
Accrued expenses			125,133	(900,622)
Restructuring reserve			(498,185)	(1,211,939)
Cash payments for expenses:
Payments made for operating lease			(62,597)	0
Net cash used in operating activities			(8,519,765)	(12,553,599)
Cash flows from investing activities:
Cash received in reverse merger transaction			0	29,106,512
Net cash provided by investing activities			0	29,106,512
Cash flows from financing activities:
Proceeds from exercise of warrants			70,459	0
Proceeds from issuance of common stock, net of issuance costs			29,756,502	750,000
Net cash provided by financing activities			29,826,961	750,000
Net increase in cash and cash equivalents			21,307,196	17,302,913
Cash and cash equivalents at beginning of period			12,161,739	103,695	$ 103,695
Cash and cash equivalents at end of period	$ 33,468,935	$ 17,406,608	33,468,935	17,406,608	$ 12,161,739
Cash paid for:
Interest			0	606
Supplemental cash flow information:
Conversion of convertible notes and accrued interest into common stock			0	32,953
Consideration in connection with reverse merger transaction			$ 0	$ 15,793,638